Press Releases

TASER Q3 Revenues Up 18% to $28.8 Million

TASER Q3 Revenues Up 18% to $28.8 MillionOct 26, 2012 (Marketwire via COMTEX) --TASER International, Inc. (NASDAQ: TASR), today announced financial results for the third quarter of 2012 ended September 30, 2012.

Financial Summary:

 

  • Net sales were $28.8 million in the quarter, an increase of $4.4 million or 18.0% compared to third quarter 2011 sales of $24.4 million. The increase in sales versus the prior year was primarily driven by the extended upgrade program for the TASER® X2™ Electronic Control Device (ECD).
     
  • Revenues in the ECD business segment sequentially remained flat with the current quarter at $27.1 million in the third quarter of 2012. In comparison to the third quarter of 2011, revenues grew 15.9% in the third quarter of 2012.
     
  • Revenues in the video business segment increased 30.8% sequentially, from $1.3 million in the second quarter of 2012 to $1.7 million in the third quarter of 2012. In comparison to the third quarter of 2011, revenues grew 65.2% in the third quarter of 2012. AXON Flex™ on-officer cameras and EVIDENCE.com bookings continued to grow with bookings doubling sequentially from the second quarter of 2012 to the third quarter of 2012.
     
  • Gross margin in the third quarter of 2012 was 58.4%, compared to 53.7% in the same period last year. The improvement in gross margin was driven by the increase in sales and the realization of ongoing operational improvements and manufacturing efficiencies.
     
  • Operating income of $5.3 million benefited from the increased gross margins as well as lower R&D expenses versus the prior year. This was a significant increase from operating income in the third quarter of 2011 of $1.2 million.
     
  • Sales, general and administrative (SG&A) expenses of $9.5 million in the third quarter of 2012 increased 13.1% sequentially, from $8.4 million the second quarter of 2012. This increase was partially a result of higher variable selling expenses, including distributor overages, which resulted from increased direct sales and internet marketing initiatives. The third quarter results also included discrete one-time expenses of $190,000 for additional stock compensation, severance and the costs associated with closing a remote facility. Personnel costs also increased sequentially as a result of annual salary merit increases and the payroll for additional strategic hires.
     
  • Research and development (R&D) expenses decreased $0.4 million to $2.0 million in the third quarter of 2012 when compared to the third quarter of 2011. The decrease was primarily attributable to the continued reduction in professional and consulting fees.
     
  • Adjusted operating income, which excludes the impact of stock-based compensation charges, depreciation and amortization and one-time litigation judgment expenses, was $7.8 million for the third quarter of 2012, a significant increase from an adjusted operating income of $4.0 million in the third quarter of 2011. GAAP income from operations was $5.3 million for the quarter, compared to income from operations of approximately $1.2 million for the third quarter of 2011.
     
  • Income taxes for the third quarter of 2012 were $1.6 million. The Company benefited from non-recurring adjustments relating to a return to provision adjustment and a rate differential true-up totaling approximately $0.5 million. The Company expects its annual effective tax rate to be approximately 40% for 2012.
     
  • Net income for the third quarter of 2012 was $3.7 million, or $0.07 per share on a basic and diluted basis. 
     
  • In the third quarter of 2012, the Company generated $9.9 million in cash from operating activities. The Company generated $23.3 million in cash from operating activities in the first nine months of 2012. 
     
  • Cash, cash equivalents and investments were $29.1 million at the end of the third quarter of 2012, after executing $3.9 million of stock repurchases during the quarter. The Company has no debt recorded on its balance sheet.
     

 

"We are encouraged by the growing momentum in our business as the X2 ECD continues to gain market traction and the installed based continues to transition to the X2," commented Rick Smith, CEO of TASER International, Inc. "The Company also saw growth in the number of agencies embracing on-officer recording systems through sales of AXON Flex on-officer cameras and EVIDENCE.com service. Sequential bookings doubled this quarter and there is growing awareness in the marketplace about the value-add of these products. As a whole, these initiatives drove an 18% year-over-year growth in our top-line results."

"Therefore, we have started to prudently reinvest into the business to fund future growth as evidenced by the uptick in SG&A expenses. We will look to tie this reinvestment directly with the sales and booking trends that we see in the future. We also continue to focus on creating a culture of operational excellence which has helped the Company deliver a third consecutive quarter of strong operational results, including significant cash generations of $9.9 million in the third quarter. We remain well positioned to deliver on the execution of our strategy to continue to generate significant operating cash flows, and to drive profitable growth and value for all of our stakeholders," concluded Smith.

Other Significant Events:

 

  • In the third quarter, the Company continued to see adoption of the new X2 ECD platform by agencies through its extended upgrade program. The Company announced a number of significant orders that occurred during the third quarter, which included:
    • The Pima County Sheriff's Office (AZ) purchased 600 X2 ECDs.
    • The Colorado Springs Police (CO) purchased 525 X2 ECDs.
    • The Indian River County Sheriff's Department (FL) purchased 249 X2 ECDs.
    • The Orange County Sheriff's Office (FL) purchased 400 X2 ECDs.
    • The Miami-Dade Police Department (FL) purchased 200 X2 ECDs.
       
  • The Company continued to see new agencies adopting the new TASER AXON Flex on-officer camera and EVIDENCE.com management service during the third quarter including:
    • The Pittsburgh Bureau of Police (PA) ordered 50 AXON Flex cameras with three full years of EVIDENCE.com.
    • The Chesapeake Police Department (MD) deployed 125 AXON Flex cameras with five years of EVIDENCE.COM.
    • The Hartford Police Department (CT) deployed 42 AXON Flex systems with one year of EVIDENCE.com.
    • The Topeka Police Department (KS) deployed 30 AXON Flex systems with three years of EVIDENCE.com.
    • The Wentzville Police Department (MO) deployed 30 AXON Flex systems with one year of EVIDENCE.com.
       
  • As previously announced, on April 25, 2012, the Board of Directors of TASER authorized a new share repurchase program for up to $20.0 million of its common stock, reflecting the Company's strong balance sheet and operating cash flow generation. As of September 30, 2012, the Company completed the program through the aggregate repurchase of 6.8% of shares outstanding totaling 3,807,606 shares of stock costing approximately $20.0 million. This was done at an average price of roughly $5.22 per share. In the past twenty-one months, the Company has repurchased a total of 11,272,189 shares or 18.7% of the total shares outstanding at the start of the buyback programs. At September 30, 2012, the Company had 52,331,988 shares outstanding.

 

The Company will host its third quarter 2012 earnings conference call on Friday, October 26, 2012 at 11:00 a.m. ET. To join the live audio presentation, please dial toll free at 866-543-6407 or 617-213-8898 for international callers. The pass code is 27220415.

Non-GAAP Measures

To supplement the Company's Statements of Operations presented in accordance with GAAP, we are presenting non-GAAP measures of certain components of financial performance. We have presented these measures for our investors to be better able to compare our current results with those of previous periods and have shown a reconciliation of GAAP to the non-GAAP financial measures in the tables at the end of this release. These non-GAAP measures include the impact of non-cash stock-based compensation expense, depreciation and amortization, litigation judgment expense, asset impairment charges and loss on write down of property and equipment. We use these non-GAAP financial measures for financial and operational decision making and as a means to evaluate period-to-period comparisons. Our management believes that these non-GAAP financial measures provide meaningful supplemental information regarding our performance by excluding certain expenses and expenditures that may not be indicative of our "recurring core business operating results," meaning our operating performance excluding non-cash charges, such as stock-based compensation, depreciation and amortization and other discrete non-cash charges that are infrequent in nature. We believe that both management and investors benefit from referring to these non-GAAP financial measures in assessing our performance and when planning, forecasting and analyzing future periods. These non-GAAP financial measures also facilitate management's internal comparisons to our historical performance and liquidity.

Caution on Use of Non-GAAP Measures

As noted previously, these non-GAAP financial measures are not consistent with GAAP because they do not reflect the impact of other non-cash charges. Management believes investors will benefit from greater transparency in referring to these non-GAAP financial measures when assessing the Company's operating results, as well as when forecasting and analyzing future periods. However, management recognizes that:

 

  • these non-GAAP financial measures are limited in their usefulness and should be considered only as a supplement to the Company's GAAP financial measures;
     
  • these non-GAAP financial measures should not be considered in isolation from, or as a substitute for, the Company's GAAP financial measures;
     
  • these non-GAAP financial measures should not be considered to be superior to the Company's GAAP financial measures; and
     
  • these non-GAAP financial measures were not prepared in accordance with GAAP and investors should not assume that the non-GAAP financial measures presented in this earnings release were prepared under a comprehensive set of rules or principles.
     

 

Further, these non-GAAP financial measures may be unique to the Company, as they may be different from non-GAAP financial measures used by other companies. As such, this presentation of non-GAAP financial measures may not enhance the comparability of the Company's results to the results of other companies.

A reconciliation of each non-GAAP financial measure to the most directly comparable GAAP financial measure or measures appears at the end of this press release.

About TASER International, Inc.

TASER International, Inc. (NASDAQ: TASR) is a global provider of safety technologies that protect life and prevent conflict. More than 16,880 public safety agencies in 107 countries rely on TASER® electronic control devices and AXON on-officer camera systems to help protect and serve. Today, the use of TASER ECDs has saved more than 97,000 lives from potential death or serious injury while TASER innovations benefit individuals and families too, providing personal protection and accountability while maintaining regard for life. Since 1994, more than 251,000 individuals have relied on TASER technology as a means for effective personal safety. Learn more about TASER International and its solutions at www.TASER.com and www.EVIDENCE.com or by calling (800) 978-2737. Be a part of the TASER community by joining us on FacebookLinkedIn, Twitter, and YouTube.

TASER® is a registered trademark of TASER International, Inc., registered in the U.S. All rights reserved. TASER logo, AXON, AXON Flex, X26, and X2 are trademarks of TASER International, Inc.

Note to Investors

To review the TASER International Safe Harbor Statement, please visit:
http://investor.taser.com/phoenix.zhtml?c=129937&p=irol-safeharbor.

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including statements, without limitation, regarding our expectations, beliefs, intentions or strategies regarding the future. We intend that such forward-looking statements be subject to the safe-harbor provided by the Private Securities Litigation Reform Act of 1995. The forward-looking information is based upon current information and expectations regarding TASER International, Inc. These estimates and statements speak only as of the date on which they are made, are not guarantees of future performance, and involve certain risks, uncertainties and assumptions that are difficult to predict. Such forward-looking statements relate to: expected revenue and earnings growth; estimations regarding the size of our target markets; successful penetration of the law enforcement market; expansion of product sales to the private security, military and consumer self-defense markets; growth expectations for new and existing accounts; expansion of production capability; new product introductions; product safety and our business model. We caution that these statements are qualified by important factors that could cause actual results to differ materially from those reflected by the forward-looking statements herein.

TASER International assumes no obligation to update the information contained in this press release. These statements are qualified by important factors that could cause our actual results to differ materially from those reflected by the forward-looking statements. Such factors include but are not limited to: (1) market acceptance of our products; (2) our ability to establish and expand direct and indirect distribution channels; (3) our ability to attract and retain the endorsement of key opinion-leaders in the law enforcement community; (4) the level of product technology and price competition for our products; (5) the degree and rate of growth of the markets in which we compete and the accompanying demand for our products; (6) risks associated with rapid technological change and new product introductions; (7) competition; (8) litigation including lawsuits resulting from alleged product related injuries and death; (9) media publicity concerning allegations of deaths and injuries occurring after use of the TASER device and the negative effect this publicity could have on our sales; (10) TASER device tests and reports; (11) product quality; (12) implementation of manufacturing automation; (13) potential fluctuations in our quarterly operating results; (14) financial and budgetary constraints of prospects and customers; (15) potential delays in international and domestics orders; (16) dependence upon sole and limited source suppliers; (17) negative reports concerning the TASER device; (18) fluctuations in component pricing; (19) government regulations and inquiries; (20) dependence upon key employees and our ability to retain employees; (21) execution and implementation risks of new technology; (22) ramping manufacturing production to meet demand; (23) medical and safety studies; (24) field test results; and (25) other factors detailed in our filings with the Securities and Exchange Commission, including, without limitation, those factors detailed in the Company's Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q.

For investor relations information please contact Erin Curtis by phone at 480-515-6330 or via email at IR@TASER.com, or Dan Behrendt, Chief Financial Officer of TASER International, Inc., 480-905-2002.

 
 
TASER International, Inc.
Consolidated Statements of Operations
(Unaudited)
         
         
    For the Three Months Ended
    September 30, 2012   September 30, 2011
             
Net sales   $ 28,772,956   $ 24,383,110
Cost of products sold     11,969,944     11,279,502
Gross margin     16,803,012     13,103,608
             
Sales, general and administrative expenses     9,539,996     9,477,548
Research and development expenses     1,985,701     2,362,721
Asset impairment     -     3,353
Loss on write down / disposal of property and equipment, net     -     47,894
             
Income from operations     5,277,315     1,212,092
             
Interest and other income, net     11,418     15,265
             
Income before provision for income taxes     5,288,733     1,227,357
Provision for income taxes     1,611,861     91,072
             
Net income   $ 3,676,872   $ 1,136,285
             
             
Income per common and common equivalent shares            
Basic   $ 0.07   $ 0.02
Diluted   $ 0.07   $ 0.02
             
Weighted average number of common and common equivalent shares outstanding            
Basic     52,509,068     58,787,274
Diluted     53,106,325     60,037,328
             
             
    For the Nine Months Ended  
    September 30, 2012     September 30, 2011  
                 
Net sales   $ 82,636,791     $ 68,698,115  
Cost of products sold     34,090,148       31,145,151  
Gross margin     48,546,643       37,552,964  
                 
Sales, general and administrative expenses     26,798,629       27,887,357  
Research and development expenses     6,156,751       7,908,420  
Litigation judgment expense     (2,200,000 )     3,301,243  
Asset impairment     -       1,353,857  
Loss on write down / disposal of property and equipment, net     -       796,353  
                 
Income (loss) from operations     17,791,263       (3,694,266 )
                 
Interest and other income, net     25,545       1,303,470  
                 
Income (loss) before provision for income taxes     17,816,808       (2,390,796 )
Provision (benefit) for income taxes     6,893,872       (1,251,981 )
                 
Net income (loss)   $ 10,922,936     $ (1,138,815 )
                 
                 
Income (loss) per common and common equivalent shares                
Basic   $ 0.19     $ (0.02 )
Diluted   $ 0.19     $ (0.02 )
                 
Weighted average number of common and common equivalent shares outstanding                
Basic     57,997,341       60,617,787  
Diluted     58,482,833       60,617,787  
                 
   
   
   
TASER International, Inc.  
Segment Reporting  
(Unaudited)  
                                       
    For the Three Months Ended  
    September 30, 2012       September 30, 2011  
                                               
      Video       ECD     Total       Video       ECD       Total  
Product sales   $ 1,528,347     $ 27,085,180     28,613,527      $ 925,836     $ 23,361,182     $ 24,287,018  
Service revenue     159,429       -     159,429       96,092       -       96,092  
Net sales     1,687,776       27,085,180     $28,772,956       1,021,928       23,361,182       24,383,110  
                                               
Cost of products sold     1,181,906       9,673,370     10,855,276       693,278       9,437,149       10,130,427  
Cost of service delivered     1,114,668       -     1,114,668       1,149,075       -       1,149,075  
Total cost of sales     2,296,574       9,673,370     11,969,944       1,842,353       9,437,149       11,279,502  
                                               
Gross margin     (608,798 )     17,411,810     16,803,012       (820,425 )     13,924,033       13,103,608  
                                               
Sales, general and administrative expenses     921,746       8,618,250     9,539,996       730,275       8,747,273       9,477,548  
Research and development expenses     942,094       1,043,607     1,985,701       1,195,250       1,167,471       2,362,721  
Asset impairment     -       -     -       -       3,353       3,353  
Loss on write down / disposal of property and equipment, net     -       -     -       -       47,894       47,894  
(Loss) income from operations   $ (2,472,638 )   $ 7,749,953     $5,277,315      $ (2,745,950 )   $ 3,958,042     $ 1,212,092  
                                               
(Loss) income from operations, normalized   $ (2,472,638 )   $ 7,749,953     $5,277,315      $ (2,745,950 )   $ 4,009,289     $ 1,263,339  
                                               
Operating margin %     -147 %     29 %   18 %     -269 %     17 %     5 %
Operating margin %, normalized     -147 %     29 %   18 %     -269 %     17 %     5 %
                                               
                                     
    For the Nine Months Ended  
    September 30, 2012     September 30, 2011  
                                     
    Video     ECD     Total     Video     ECD     Total  
Product sales   $ 3,464,606     $ 78,774,581     $ 82,239,187     $ 2,420,960     $ 66,025,172     $ 68,446,132  
Service revenue     397,604       -       397,604       251,983       -       251,983  
Net sales     3,862,210       78,774,581       82,636,791       2,672,943       66,025,172       68,698,115  
                                                 
Cost of products sold     2,712,678       28,068,676       30,781,354       1,955,722       25,686,372       27,642,094  
Cost of service delivered     3,308,794       -       3,308,794       3,503,057       -       3,503,057  
Total cost of sales     6,021,472       28,068,676       34,090,148       5,458,779       25,686,372       31,145,151  
                                                 
Gross margin     (2,159,262 )     50,705,905       48,546,643       (2,785,836 )     40,338,800       37,552,964  
                                                 
Sales, general and administrative expenses     2,425,228       24,373,401       26,798,629       2,270,006       25,617,351       27,887,357  
Research and development expenses     3,350,708       2,806,043       6,156,751       3,422,452       4,485,968       7,908,420  
Litigation judgment expense     -       (2,200,000 )     (2,200,000 )     -       3,301,243       3,301,243  
Asset impairment     -       -       -       -       1,353,857       1,353,857  
Loss on write down / disposal of property and equipment, net     -       -       -       711,243       85,110       796,353  
(Loss) income from operations   $ (7,935,198 )   $ 25,726,461     $ 17,791,263     $ (9,189,537 )   $ 5,495,271     $ (3,694,266 )
                                                 
(Loss) income from operations, normalized   $ (7,935,198 )   $ 23,526,461     $ 15,591,263     $ (8,478,294 )   $ 10,235,481     $ 1,757,187  
Operating margin %     -205 %     33 %     22 %     -344 %     8 %     -5 %
Operating margin %, normalized     -205 %     30 %     19 %     -317 %     16 %     3 %
                                                 
                                                 
                             
                             
TASER International, Inc.
Reconciliation of GAAP to Non-GAAP Financial Measures
(Unaudited)
 
    For the Three Months Ended
    September 30, 2012   September 30, 2011
                             
    Video     ECD   Total   Video     ECD   Total
GAAP (loss) income from operations   $ (2,472,638 )   $ 7,749,953   $ 5,277,315   $ (2,745,950 )   $ 3,958,042   $ 1,212,092
  Stock-based compensation expense (a)     99,179       750,211     849,390     81,747       611,773     693,520
  Depreciation and amortization     664,307       1,054,239     1,718,546     663,527       1,331,505     1,995,032
  Asset impairment     -       -     -     -       3,353     3,353
  Loss on write down / disposal of property and equipment, net     -       -     -     -       47,894     47,894
Adjusted operating (loss) income   $ (1,709,152 )   $ 9,554,403   $ 7,845,251   $ (2,000,676 )   $ 5,952,567   $ 3,951,891
                                         
a) Results include stock-based compensation as follows:
 
    For the Three Months Ended
    September 30, 2012   September 30, 2011
         
Cost of products sold   $ 38,085   $ 30,238
Sales, general and administrative expenses     657,870     518,513
Research and development expenses     153,435     144,769
    $ 849,390   $ 693,520
             
   
    For the Nine Months Ended  
    September 30, 2012     September 30, 2011  
    Video     ECD     Total     Video     ECD   Total  
GAAP (loss) income from operations   $ (7,935,198 )   $ 25,726,461     $ 17,791,263     $ (9,189,537 )   $ 5,495,271   $ (3,694,266 )
  Stock-based compensation expense (a)     285,292       1,851,209       2,136,501       309,114       2,224,330     2,533,444  
  Depreciation and amortization     1,777,586       3,336,403       5,113,989       1,977,570       4,135,042     6,112,612  
  Litigation judgment expense     -       (2,200,000 )     (2,200,000 )     -       3,301,243     3,301,243  
  Asset impairment     -       -       -       -       1,353,857     1,353,857  
  Loss on write down / disposal of property and equipment, net     -       -       -       -       796,353     796,353  
Adjusted operating (loss) income   $ (5,872,320 )   $ 28,714,073     $ 22,841,753     $ (6,902,853 )   $ 17,306,096   $ 10,403,243  
   
         
a) Results include stock-based compensation as follows:        
    For the Nine Months Ended
    September 30, 2012   September 30, 2011
         
Cost of products sold   $ 100,248   $ 135,217
Sales, general and administrative expenses     1,614,160     1,891,258
Research and development expenses     422,093     506,969
    $ 2,136,501   $ 2,533,444
   
   
   
TASER International, Inc.       
Consolidated Balance Sheets       
(Unaudited)       
             
             
    September 30, 2012     December 31, 2011  
ASSETS                
                 
Current Assets:                
Cash and cash equivalents   $ 25,965,711     $ 21,300,733  
Short-term investments     3,178,050       5,108,189  
Accounts receivable, net of allowance of $325,000 and $450,000 at September 30, 2012 and December 31, 2011, respectively     14,551,275       11,780,135  
Inventory     10,430,832       11,484,761  
Prepaid expenses and other current assets     2,268,761       2,089,676  
Deferred income tax assets, net     7,082,926       9,968,929  
Total current assets     63,477,555       61,732,423  
                 
Property and equipment, net     22,650,797       26,845,220  
Deferred income tax assets, net     12,716,169       12,716,169  
Intangible assets, net     3,332,276       3,224,006  
Other long-term assets     409,940       444,933  
                 
Total assets   $ 102,586,737     $ 104,962,751  
                 
LIABILITIES AND STOCKHOLDERS' EQUITY                
                 
Current Liabilities:                
Accounts payable   $ 4,259,347     $ 4,513,938  
Accrued liabilities     8,929,766       7,643,004  
Current portion of deferred revenue     3,898,535       3,317,641  
Customer deposits     327,640       413,314  
Total current liabilities     17,415,288       15,887,897  
Deferred revenue, net of current portion     6,649,519       4,636,901  
Liability for unrecorded tax benefits     2,206,551       1,982,399  
                 
Total liabilities     26,271,358       22,507,197  
                 
Commitments and Contingencies                
                 
Stockholders' Equity                
Preferred stock, $0.00001 par value per share; 25 million shares authorized; no shares issued and outstanding at September 30, 2012 and December 31, 2011, respectively     -       -  
Common stock, $0.00001 par value per share; 200 million shares authorized; 52,331,988 and 55,696,608 shares issued and outstanding at September 30, 2012 and December 31, 2011, respectively     657       652  
Additional paid-in capital     104,525,144       101,597,626  
Treasury stock, 13,363,789 and 2,091,600 shares at September 30, 2012 and December 31, 2011, respectively     (67,203,043 )     (47,207,093 )
Retained earnings     39,068,261       28,145,325  
Accumulated other comprehensive loss     (75,640 )     (80,956 )
Total stockholders' equity     76,315,379       82,455,554  
                 
Total liabilities and stockholders' equity   $ 102,586,737     $ 104,962,751  
                 
                 
                 
   
TASER International, Inc.  
Selected Consolidated Statement of Cash Flows Information  
(Unaudited)  
             
    For the Nine Months Ended  
    September 30, 2012     September 30, 2011  
                 
Net income (loss)   $ 10,922,936     $ (1,138,815 )
Depreciation and amortization     5,113,989       6,112,612  
Stock-based compensation expense     2,136,501       2,533,444  
Net cash provided by operating activities     23,258,163       14,637,384  
Net cash provided by (used in) investing activities     676,690       (7,813,187 )
Net cash used in financing activities     (19,265,477 )     (24,845,271 )
Cash and cash equivalents, end of period     25,965,711       24,574,858  
                 
                 
CONTACT: 
        Dan Behrendt 
        Chief Financial Officer
        TASER International, Inc.
        (480) 905-2000